About neotiv

neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases (DZNE). neotiv incorporates the latest scientific findings from the fields of neuroscience and dementia research into mobile software that can be used on smartphones and tablets. Our work focuses on the development of a digital assistant that can monitor and aid users' memories and provide support for patients with dementia. neotiv is also designed to improve the early detection of Alzheimer's dementia and to facilitate efficacy monitoring for new therapies as they become available in the future. Biologically and anatomically valid and user-oriented measurements of specific memory functions, which can be carried out on a regular basis, form the core of the development of neotiv. The measurements focus on regions of the brain that are affected in the early stages of Alzheimer's disease. The vision behind neotiv is to (i) help reducing risk factors for cognitive decline by making lifestyle change simple and cognitive health measurable and (ii) to enable the innovative early detection of cognitive difficulties and dementia risk.

Press releases

9. November 2022

10 million euros in Pre-Series A financing round: neotiv can accelerate international product launch in the fight against Alzheimer’s disease

Magdeburg-based digital health company neotiv, which is working on the development of digital biomarkers for early Alzheimer’s screening, has successfully expanded its Pre-Series A financing round and raised 10 million euros. With the additional funds, neotiv is now able to drive nationwide supply of the neotivCare® app, accelerate internationalization, and fight Alzheimer’s. Magdeburg, November 9 2022– The funding of 10 million euros is led by renowned investors Ca
16. January 2018

Digital health start-up neotiv secures seed funding from High-Tech Gründerfonds

From basic research straight to a digital medical product: this vision has been turned into reality by neotiv. The team headed by Chief Executive Officer Dr. Chris Rehse and dementia researcher Prof. Emrah Düzel develops user-friendly apps that are able to measure the psychological effects of Alzheimer's disease in its early stage. The Magdeburg-based start-up is thus bringing the latest findings in the field of neurodegenerative disease research to mobile apps for private users, doctors and dr

Info & Contact

Dr. Chris Rehse


neotiv GmbH
Sandtorstraße 23
39106 Magdeburg

In portfolio

21. Sep 2017

Kay G. Balster

Principal / Authorized signatory